Embla Medical hf. 5IQ.F

Healthcare · Medical Devices · valued as of 2026-11-02 · statements 2025-12-31

Average Intrinsic Value
$1.09B
Market Cap
$1.67B
Margin of Safety
-53.5%
Intrinsic / Market Ratio
0.65

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

990.39M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

1.24B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.04B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

1.09B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

1.09B USD

from the sum above

Market Cap

1.67B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.65×

the ratio the screener ranks by; Margin of Safety -53.5% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 990.39M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)1.36B USD
−②Net Debt Today435.63M USD
+③Growth Value64.17M USD
=Value990.39M USD

EPV of the Operations (NOPAT over WACC)

1.36B USD

Net debt today

-435.63M USD

Growth Value

+64.17M USD

Value

990.39M USD

①EPV (earnings power value)

1.36B USD

②Net Debt Today

435.63M USD

③Growth Value

64.17M USD

Market value

Market Cap1.67B USD

Today's price times the shares.

Value vs market

Margin of Safety-68.5%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 1.24B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE523.54M USD
+②Equity at Year 15, Today712.21M USD
=Value1.24B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

523.54M USD

②Equity at Year 15, Today

712.21M USD

Market value

Market Cap1.67B USD

Today's price times the shares.

Value vs market

Margin of Safety-35.1%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.04B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF825.76M USD
+②Invested Capital at Year 15, Today645.85M USD
−③Net Debt Today435.63M USD
=Value1.04B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

825.76M USD

②Invested Capital at Year 15, Today

645.85M USD

③Net Debt Today

435.63M USD

Market value

Market Cap1.67B USD

Today's price times the shares.

Value vs market

Margin of Safety-61.1%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.19%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.46×Market Risk Premium 6.00%= 7.26%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 24.32M USDPretax Income 108.04M USD= 22.51%

The tax the interest saves.

Interest Expense =EBIT 127.59M USD−Pretax Income 108.04M USD= 19.54M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 19.54M USDTotal Debt 534.50M USD×(1 − Tax Rate for WACC 22.51%)= 2.83%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 534.50M USDMarket Cap + Total Debt 1.67B USD + 534.50M USD= 24.26%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 75.74%×Cost of Equity 7.26%+Debt Weight 24.26%×Cost of Debt 2.83%= 6.19%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 1.72B USD − Total Liabilities 792.22M USD = Book Value Today 926.95M USD

Total Debt 534.50M USD − Cash and Short-Term Investments 98.87M USD = Net Debt Today 435.63M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 11.3%at most 5%passes425,911,905 / 420,298,353
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.9%at least -10.0%passes(132.75M USD − 83.42M USD) ÷ 1.72B USD
Price to bookMarket Cap ÷ Book Value Today1.80×at most 3×passes1.67B USD ÷ 926.95M USD
Operating marginOperating Income ÷ Revenue13.4%above 10.0%passes124.82M USD ÷ 929.62M USD
Revenue growthRevenue ÷ Revenue a Year Before − 18.6%above 10.0%does not pass929.62M USD / 855.74M USD
Net cash(Cash − Total Debt) ÷ Market Cap-26.1%above -30%passes(98.87M USD − 534.50M USD) ÷ 1.67B USD
Operating efficiencyOperating Income ÷ Gross Profit21.6%above 25.0%does not pass124.82M USD ÷ 579.13M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

4 USD

Enterprise value

1.98B USD

market cap plus net debt

EV / EBITDA

12.50×

Price / book

1.89×

the provider's book

Price / earnings

18.42×

Return on equity

10.7%

the provider's, not the engine's

Profit margin

9.5%

Revenue growth

11.3%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

719.37M786.47M855.74M929.62M

Gross profit

440.19M486.06M535.23M579.13M

Operating income

67.21M87.55M112.87M124.82M

EBITDA

operating income before depreciation and amortisation

116.86M144.03M169.95M188.27M

Pretax income

56.23M76.08M90.65M108.04M

Net income

42.56M58.45M68.35M83.42M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

42.56M58.45M68.35M83.42M

R&D

34.06M38.18M40.87M45.90M
Balance sheet, year end

Total assets

1.33B1.39B1.54B1.73B

Total liabilities

690.54M681.36M759.02M835.52M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

636.34M702.58M777.96M891.44M

Total debt

481.40M468.20M500.29M542.11M

Cash and equivalents

76.71M72.73M86.25M102.61M

Net PP&E

fixed assets after depreciation

179.50M186.25M199.82M242.97M

Working capital

current assets less current liabilities

111.95M179.96M187.86M148.58M
Cash flow

Operating cash flow

60.83M94.42M116.18M132.75M

Capital expenditure

paid out, so below zero

-25.97M-42.32M-39.27M-32.36M

Depreciation and amortisation

49.41M49.97M56.03M60.68M

Free cash flow

operating cash flow plus capital expenditure

34.86M52.10M76.92M100.39M